Inactivated vaccines were prepared from cell-associated vaccinia virus liberated mechanically from sheep dermal pulp and cultures of infected chick cells and from naturally released 'free' or extracellular virus. The inactivated vaccines induced dermal immunity in rabbits and protected mice against intracerebral challenge. Antibody produced by rabbits in response to inactivated cell-associated virus neutralized cell-associated but not free virus. Antibody to inactivated 'free' virus neutralized neither, whereas antibody to live virus neutralized both types of virus and prevented secondary spread in vitro. Antigenic differences between cellassociated and 'free' virus were also indicated by gel precipitation but not by complement fixation or haemagglutination-inhibition tests on the sera.
INTRODUCTION
Differences in virus neutralizing antibody evoked by live and inactivated vaccinia virus were demonstrated in cross absorption experiments (Madeley, I968 ) . Qualitative differences in antibodies to live and inactivated vaccines were also noted in preliminary studies with rabbitpox virus by Boulter (1969) who explained them by suggestingthat artificially liberated intracellular pox virus differs antigenically from naturally occurring extracellular virus. These findings have an obvious bearing on many previous attempts to prepare effective inactivated smallpox vaccine (Turner, Squires & Murray, I97O) . Mechanical disruption of infected cellular material is the conventional method of preparing smallpox vaccine. This does not affect the efficacy of live vaccine which produces both free and cell-associated virus on multiplication; but it may be inferred that the inactivated vaccines prepared hitherto contained mostly cell-associated virus. Following Boulter's original report (I969), we have examined live and inactivated vaccines prepared from vaccinia virus extracted by conventional methods from sheep dermal pulp or from extra-and intracellular virus grown in cell cultures. The immunogenicity of the vaccines was assessed from antibody response and skin immunity in rabbits and from protection tests in mice.
METHODS
Viruses. The LISTER INSTITUTE strain of vaccinia virus was used for preparing vaccines, for serum neutralization tests and for dermal challenge of rabbits. The mouse neurotropic strain WR was used for intracerebral challenge of mice.
Virus assay. Virus was titrated either by pock counts on chorioallantoic membranes (CAM) of I z-day chick embryos or by plaque counts in cultures of chick embryo fibroblasts or RK 13 cells. For both assays o.I ml. volumes of suitable dilutions were inoculated and counts were made after 48 hr incubation. Mean titres from six membranes or six cell cultures are expressed either as pk.f.u./ml, or p.flu./ml.
Virus preparations. Virus from sheep dermal pulp was extracted and purified by the methods of Turner et al. (I97O) . Intracellular virus could not be easily separated from extracellular virus in this material and for this purpose virus was propagated in large-scale roller cultures of primary chick embryo cells. Cells infected at an input multiplicity of o.I were maintained in Eagles' minimum essential medium containing 2 % heat-inactivated calf serum. After 4 days incubation the culture fluid was decanted and centrifuged at 6oo g to remove any gross cellular debris. The clear supernatant fluid containing z % or less of the total virus yield was centrifuged at lO,OOO g for 9 ° min. The pellets were resuspended in dilute phosphate-buffered saline in 1/5o to I/2O of the original fluid volume and designated ' extracellular' or free virus.
The infected cell sheets from the culture bottles were detached with sterile glass beads, suspended in dilute phosphate-buffered saline and disrupted by ultrasonic vibration at 2o kcyc./sec. The suspensions were centrifuged at 6oog to remove cell debris. The supernatant fluid contained intracellular or 'cell-associated' virus. All preparations were stored at -16o °.
Preparation of inactivated vaccines. Virus samples from sheep and free virus and cellassociated virus from chick cell cultures were inactivated by dye and visible light (Turner & Kaplan, ~965 ). They were rigorously tested to exclude the presence of residual live virus (Madeley, 1968; Turner et al. I97O) .
Immunization of rabbits. Inactivated virus from sheep was emulsified with an equal volume of Freund's complete adjuvant and the equivalent of lO 9 to IO 10 pk.f.u, was inoculated subcutaneously into two or three rabbits (Boulter, Zwartouw & Titmus, 1964) . Forty days later an intravenous dose of the same material was given without adjuvant. Inactivated free virus and cell-associated virus vaccines from chick cells were similarly tested. The adjuvant doses contained the equivalent of IO s'7 pk.f.u. Other rabbits were hyperimmunized with live virus from sheep or from chick cell culture. Scarification with approximately lO 7 pk.f.u. was followed 4 o days later by an intravenous dose of lO 9 pk.f.u. These animals were housed in an area separate from those receiving killed vaccine. Rabbits were bled before immunization and IO days after the second dose. Sera were separated, inactivated at 560 and stored at -I5 °.
Antibody assays. Virus neutralizing antibody responses of rabbits to the different vaccines were assayed by inhibition of plaque formation in monolayer cultures of chick embryo cells (Turner & Kaplan, 1965) . Suitable dilutions of serum were mixed with conventionally prepared challenge virus which had been diluted in 2o % skimmed milk to contain approximately lOO p.f.u./culture. After incubation at 37 ° for 2 hr, six cultures were each inoculated with o.I ml. of each serum + virus mixture. The international standard smallpox antiserum was included in each group of assays. Plaques were counted after incubation for 48 hr at 37 °; neutralizing potencies were calculated in international units from dose response curves of the unknown and standard antisera. Similar methods were used to determine qualitative differences in the neutralizing capacities of these sera against free virus and cell-associated virus when serial tenfold dilutions were tested with suitable challenge doses of each type of virus.
Methods for estimating complement-fixing and haemagglutination-inhibiting antibodies and for gel precipitation tests were those of Turner et al. (I97o) .
Antibody modification of plaque development. Immunogenicity of inactivated smallpox 2I the residual inoculum was removed. The cultures were then overlaid with liquid medium containing lO% or x % of serum from rabbits immunized with the different vaccines. The total serum content in test and control cultures was adjusted to IO % with normal rabbit serum. Cultures were stained and plaques were examined after z, 3 and 5 days incubation. Dermal immunity in rabbits. Inactivated sheep virus, free virus, and cell-associated virus vaccines were each tested in two rabbits by giving the animals two intramuscular doses one week apart. Two rabbits were immunized at the same time with live virus of either chick cell or sheep origin by dermal scarification with Io 7 pk.f.u. Two uninoculated rabbits served as controls. Twelve days after the second dose of killed vaccine, o.I ml. volumes of serial fivefold dilutions of live virus were applied to the scarified skin of all the rabbits. The animals were inspected daily following challenge and the degree of skin resistance was determined from readings on the fifth day. Observations were continued for a further 9 days to note any modification of the lesions.
Mouse protection tests. Serial tenfold dilutions of live and inactivated free virus and cellassociated virus vaccines were tested. Each dilution was used to immunize a group of IO mice. Two subcutaneous injections of o'5 ml. were given one week apart. One week after the second dose the mice were challenged intracerebrally with an estimated 5 to 5o LD 5o of the neurotropic vaccinia strain WR. At each test the challenge virus was titrated in normal mice of the same batch. The 5 ° % effective dose (ED 5o) of each vaccine was calculated as the number of pk.f.u, of virus, live or inactive, protecting 5o % of the mice against lethal challenge. Although the passive protection of mice against intracerebral challenge was unlikely, the hyperimmune rabbit sera prepared against live and inactivated sheep vaccine were tested for this property. Groups of ten mice were given 6oo i.u. of antiserum intraperitoneally 2 hr before challenge and then daily for 7 days.
RESULTS

Immunogenicity in rabbits Antibody responses
When assayed with conventionally prepared virus from sheep, no antibodies were detectable in any pre-immunization serum and rabbits immunized with virus prepared from sheep, either live or inactivated+adjuvant, responded with high titres of neutralizing antibody (Table I) . Complement-fixing antibody response to both vaccines was also high; the low haemagglutinin-inhibiting antibody response to killed vaccine prepared from sheep accords with previous findings (Turner et al. I97o ) . Although less than those induced by sheep virus, virus-neutralizing antibody response either to live virus or to inactivated cell-associated virus from chick cells was substantial when measured with the sheep virus challenge above. Similar doses of inactivated free virus in adjuvant stimulated no virus-neutralizing antibody under the same conditions, and detectable amounts were only produced after repeated injections. Nevertheless, responses to inactivated free virus measured by haemagglutinin inhibition or complement fixation were similar to those obtained with live virus of chick origin.
When the same sera were retested with either free virus or cell-associated virus as challenge, antiserum to live virus of either chick cell or sheep origin neutralized both types of virus (Fig. I a) . Antiserum to inactivated sheep virus or inactivated chick cell-associated virus neutralized cell-associated virus, but less than 5o % of the free virus challenge was neutralized at any serum concentration tested (Fig. I b, ~ c) . Antiserum to inactivated free virus neutralized neither free virus nor cell-associated virus (Fig. I d) . These results confirm the 
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antigenic differences between intra-and extracellular virus (Boulter, 1969; Appleyard, Hapel & Boulter, ~97I) and also suggest that the antigens responsible for inducing neutralizing antibody are lost from free virus when it is inactivated.
Gel precipitin tests
Analysis by precipitation in gel gave a complex pattern in which antibody to inactivated sheep virus showed a clear reaction of non-identity with antibody to live sheep virus: antibody to inactivated chick free virus also clearly differed from that induced by live chick virus or inactivated cell-associated chick virus (Fig. 2) . 
Antibody modification of plaque development
Antibody to live virus, added to the liquid overlays of cell monolayers pre-infected with vaccinia virus, prevented secondary spread and restricted plaque size. Antiserum to inactivated cell-associated virus or free virus did not modify plaque development; plaques increased in size, and secondary satellite plaques appeared as in control cultures containing normal serum. After 3 to 5 days incubation, differences were clearer in monolayers of RK I3 cells than in chick cells. The 'comet'-like tails of secondary virus spread (Appleyard et al. I97I) were not regularly observed with LISTER strain vaccinia virus.
Dermal immunity
Challenge virus doses causing confluent or semiconfluent lesions in the skin of control rabbits induced fewer lesions in rabbits immunized with inactivated sheep, cell-associated virus or free virus vaccines and none in animals immunized with live virus (Table 2 ). The development of lesions was accelerated in animals immunized with inactivated vaccines. The G. S. TURNER AND E. J. SQUIRES inactivated cell-associated and inactivated free virus vaccines conferred a degree of dermal immunity unrelated to the different humora! antibody responses recorded above.
lmmunogenicity in mice
Mice immunized with inactivated cell-associated and free virus vaccines survived intracerebral challenge with 26 LD5o of vaccinia strain WR. Doses protecting 5 o % of mice (ED 5 o) were io 7"5 pk.f.u, for cell-associated virus and Io 6"~ pk.f.u, for free virus. The ED 50 of live virus was IOOO-to IO,OOO-fold less 0@ .6 pk.f.u.). Differences between the inactivated vaccines were not statistically significant and the results were similar to those reported previously (Turner et al. I97O ). Mice were not passively protected against a similar intracerebral challenge by daily doses of 60o i.u. of sera from rabbits hyperimmunized with either live or with inactivated vaccine. 
DISCUSSION
Comparison of the humoral responses assessed by different methods permitted no simple antigenic analysis of the vaccines. Gel precipitation tests clearly distinguished antisera to live virus from those produced in response to inactivated cell-associated virus. It is possible that the missing components in the latter are related to its inability to neutralize free virus. However, differences between these sera were not demonstrated by complement fixation or haemagglutination inhibition (Table I , Fig. I and 2 ). Complement fixation and haemagglutination inhibition also failed to distinguish antisera to inactivated free virus from antisera to the parent live virus. The failure of inactivated free virus to elicit more than traces of neutralizing antibody to either form of virus and its reaction of non-identity in gel precipitation tests might be consistent with the acquisition of a ' coat' and new antigenic determinants. However, our preparations of both free and cell-associated virus examined in the electron microscope by Mrs J. D. Almeida of the Royal Post Graduate Medical School, exhibited typical poxvirus morphology but no virus 'coat'. Such a 'coat' acquired at the cell surface might be expected to retain some host specificity, but extracellular virus prepared in chick cells was not neutralized by potent anti-chick-cell serum (G. S. Turner & L. Runkel, unpublished observations) . In most other respects our results amply confirm those reported by Boulter (I969) and Appleyard et al. 0970 It has been suggested that an inactivated smallpox vaccine might be effective only if made from 'free' or extracellular virus (Gordon-Smith, 1970) . Our results suggest that if immunity to the pox viruses depends solely on circulating, virus neutralizing antibody, inactivated vaccine prepared from either type of virus would be valueless. Virus neutralizing antibody induced by inactivated vaccine has defects that obviously preclude its use in the passive treatment of smallpox or the complications of vaccination (British Medical Journal, ~97o), nor can true immunity to smallpox be assessed in neutralization tests by using the cellassociated component as test virus (Appleyard et al. I97 0. The non-humoral factors in the complex immune response to the pox viruses suggest, however, that the use of inactivated vaccine might still circumvent some of the problems associated with the live product. Boulter (I969) reported that, although illness and skin rash were not prevented, 25 rabbits immunized with inactivated vaccinia virus survived a rabbit-pox challenge that killed ~4 of ~5 normal controls. Rabbits immunized with heat-killed vaccinia virus also survived a lethal rabbit-pox challenge without detectable viraemia or secondary spread, although some skin lesions and pyrexia occurred (Madeley, I968) . Our findings show that inactivated vaccines prepared from both 'cell-associated' and 'free' virus confer dermal immunity in rabbits. They also protect mice from a lethal challenge much more severe than might be expected in natural infection.
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